|
GNA13 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.00050000000096E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.059300E-03 |
| Normal-vs-Stage2 |
9.921400E-03 |
| Normal-vs-Stage3 |
2.426200E-02 |
| Normal-vs-Stage4 |
1.813960E-01 |
| Stage1-vs-Stage2 |
5.621600E-01 |
| Stage1-vs-Stage3 |
3.420400E-01 |
| Stage1-vs-Stage4 |
2.509400E-01 |
| Stage2-vs-Stage3 |
7.961600E-01 |
| Stage2-vs-Stage4 |
2.844400E-01 |
| Stage3-vs-Stage4 |
3.045000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.036670E-04 |
| Normal-vs-AfricanAmerican |
6.164100E-02 |
| Normal-vs-Asian |
3.762400E-01 |
| Caucasian-vs-AfricanAmerican |
5.872200E-02 |
| Caucasian-vs-Asian |
9.661200E-01 |
| AfricanAmerican-vs-Asian |
4.810800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.501690E-03 |
| Normal-vs-Female |
2.04939999999265E-05 |
| Male-vs-Female |
1.009990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.375840E-01 |
| Normal-vs-Extreme_Weight |
3.444000E-02 |
| Normal-vs-Obese |
7.440000E-04 |
| Normal-vs-Extreme_Obese |
1.463220E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.268600E-01 |
| Normal_Weight-vs-Obese |
9.805600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.498600E-01 |
| Extreme_Weight-vs-Obese |
7.646400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.607000E-01 |
| Obese-vs-Extreme_Obese |
7.928200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.458000E-03 |
| Normal-vs-Age(41-60Yrs) |
4.162400E-04 |
| Normal-vs-Age(61-80Yrs) |
2.194400E-02 |
| Normal-vs-Age(81-100Yrs) |
8.205600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.437600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.069800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.418700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.502200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.851600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.160000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.455620E-03 |
| Normal-VS-Type2 PRCC |
2.657600E-02 |
| Normal-VS-KIRP CIMP |
2.174300E-02 |
| Normal-VS-Unclassified PRCC |
8.523500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.135800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.358300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.474800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.363170E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.136400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.616300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.347600E-02 |
| Normal-vs-N1 |
4.027500E-02 |
| Normal-vs-N2 |
2.365600E-01 |
| N0-vs-N1 |
8.835600E-02 |
| N0-vs-N2 |
3.408400E-01 |
| N1-vs-N2 |
8.416800E-01 |
|
|
